Monoclonal antibody significantly reduces nasal polyps and need for surgery in Phase 3 clinical trial

Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 inflammatory responses drive disease progression. Treatments such as intranasal glucocorticoids and sinus surgery provide limited long-term relief and fail to address the underlying inflammatory mechanisms.
Read More

Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer’s disease

The herb rosemary has long been linked with memory. “There’s rosemary, that’s for remembrance,” says Ophelia in Shakespeare’s “Hamlet.” So it is fitting that researchers would study a compound found in rosemary and sage—carnosic acid—for its impact on Alzheimer’s disease. In the disease, which is the leading cause of dementia and the sixth-leading cause of death in the US, inflammation is one component that often leads to cognitive decline.
Read More
Top